NO893431L - Fremgangsmaate for fremstilling av neuropeptid y antagonister. - Google Patents

Fremgangsmaate for fremstilling av neuropeptid y antagonister.

Info

Publication number
NO893431L
NO893431L NO89893431A NO893431A NO893431L NO 893431 L NO893431 L NO 893431L NO 89893431 A NO89893431 A NO 89893431A NO 893431 A NO893431 A NO 893431A NO 893431 L NO893431 L NO 893431L
Authority
NO
Norway
Prior art keywords
preparation
neuropeptide
antagonists
procedure
nie
Prior art date
Application number
NO89893431A
Other languages
English (en)
Norwegian (no)
Other versions
NO893431D0 (no
Inventor
John Leonard Krstenansky
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO893431D0 publication Critical patent/NO893431D0/no
Publication of NO893431L publication Critical patent/NO893431L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57545—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO89893431A 1988-08-26 1989-08-25 Fremgangsmaate for fremstilling av neuropeptid y antagonister. NO893431L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23759988A 1988-08-26 1988-08-26

Publications (2)

Publication Number Publication Date
NO893431D0 NO893431D0 (no) 1989-08-25
NO893431L true NO893431L (no) 1990-02-27

Family

ID=22894403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893431A NO893431L (no) 1988-08-26 1989-08-25 Fremgangsmaate for fremstilling av neuropeptid y antagonister.

Country Status (15)

Country Link
EP (1) EP0355794B1 (fr)
JP (1) JPH02111793A (fr)
KR (1) KR900003203A (fr)
CN (1) CN1040594A (fr)
AT (1) ATE100466T1 (fr)
DE (1) DE68912453T2 (fr)
DK (1) DK421489A (fr)
ES (1) ES2061839T3 (fr)
FI (1) FI894007L (fr)
HU (1) HU204541B (fr)
IL (1) IL91396A0 (fr)
NO (1) NO893431L (fr)
NZ (1) NZ230385A (fr)
PT (1) PT91539B (fr)
ZA (1) ZA896374B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229283T2 (de) * 1991-11-06 1999-09-23 Garvan Institute Of Medical Research, Darlinghurst Humaner neuropeptid y-y1 rezeptor
GB9213215D0 (en) * 1992-06-20 1992-08-05 Wellcome Found Peptides
US5516653A (en) * 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5989920A (en) * 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
WO2004098591A2 (fr) 2003-05-05 2004-11-18 Probiodrug Ag Inhibiteurs de glutaminyl-cyclase
AU2004290499C1 (en) 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
CA2554809C (fr) 2004-02-05 2014-04-29 Probiodrug Ag Nouveaux inhibiteurs de la glutaminyl-cyclase comportant de la n thiouree alkyle et de l'imidazolyl substitue par thioamide
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (fr) 2007-04-18 2014-12-24 Probiodrug AG Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase
EP2264026A4 (fr) 2008-03-06 2012-03-28 Msd Kk Dérivé d'alkylaminopyridine
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
NZ602312A (en) 2010-03-10 2014-02-28 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (fr) 2010-04-21 2011-10-27 Probiodrug Ag Nouveaux inhibiteurs
EP2686313B1 (fr) 2011-03-16 2016-02-03 Probiodrug AG Dérivés de benzimidazole en tant qu'inhibiteurs de la glutaminyl cyclase
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Also Published As

Publication number Publication date
FI894007A7 (fi) 1990-02-27
PT91539B (pt) 1995-05-04
DK421489D0 (da) 1989-08-25
KR900003203A (ko) 1990-03-26
ES2061839T3 (es) 1994-12-16
EP0355794A2 (fr) 1990-02-28
HU204541B (en) 1992-01-28
FI894007A0 (fi) 1989-08-25
EP0355794A3 (fr) 1991-01-23
PT91539A (pt) 1990-03-08
DK421489A (da) 1990-02-27
EP0355794B1 (fr) 1994-01-19
CN1040594A (zh) 1990-03-21
HUT50486A (en) 1990-02-28
JPH02111793A (ja) 1990-04-24
NZ230385A (en) 1992-04-28
ATE100466T1 (de) 1994-02-15
DE68912453T2 (de) 1994-05-11
IL91396A0 (en) 1990-04-29
AU4017689A (en) 1990-03-01
NO893431D0 (no) 1989-08-25
FI894007L (fi) 1990-02-27
ZA896374B (en) 1990-05-30
AU620432B2 (en) 1992-02-20
DE68912453D1 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
NO893431L (no) Fremgangsmaate for fremstilling av neuropeptid y antagonister.
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
ES2135416T3 (es) Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.
CA2247443A1 (fr) Derives d'acide 4-hydroxy-phenylalcanoique substitue possedant une activite agoniste envers ppar-gamma
ES8100261A1 (es) Un procedimiento para la preparacion de un indol
ES2179318T3 (es) Derivados de acido cinamico y su uso como antagonistas de integrina.
TR27055A (tr) Yeni hetorosiklik bilesikler hazirlanmasina mahsus usul ve ensektisitler olarak kullanilmalari.
DK0883616T3 (da) Dihydrobenzofuranforbindelser og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DE69111029D1 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
DE3785136D1 (de) Arzneimittel zur inhibition von hautfalte.
ES469952A1 (es) Un procedimiento para la preparacion de aminoalquiltiofenos
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
FI810250L (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva heterocykliska foereningar
DE3370481D1 (en) Dihydropyridines
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
IE872588L (en) Compounds
NO850224L (no) Fremgangsmaate ved fremstilling av 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner
GB1433701A (en) 5-6-benzene ring substituted benzimidazole-2-carbamate derivative having anthelmintic activity apparatus
NO149998C (no) Analogifremgangsmaate til fremstilling av peptider med ubiquitinlignende aktivitet.
NO964551L (no) Imidazolderivater og fremgangsmåte for fremstilling av slike
ES2042497T3 (es) Derivados lactamicos, su preparacion y su uso como agentes hipotensores.
DK0891346T3 (da) Dihydrobenzofuranforbindelser, der er nyttige som antiinflammatoriske midler
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.